RxDoctor Payments Data

Stephen Ramondino, MD

Psychiatry · Monterey, CANPI 1942388657

Payments from drug & device makers

$8,580in general payments, 2019–2025

Across 424 payments — averaging $20.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Johnson & Johnson$999
  • Takeda Pharmaceuticals U.S.A., Inc.$737
  • Tris Pharma Inc$583
  • Teva Pharmaceuticals USA, Inc.$570
  • Neurocrine Biosciences, Inc.$513
  • plus $4K from 21 others

What the payments were for

  • Food & beverage$8,51399%
  • Education$671%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$8,580 in reported general payments places this provider in the 90th percentile of 4,954 psychiatry providers in California.

See all psychiatry providers in California

Medicare billing

Part B allowed, 2024
$354,605
Medicare patients
59
Services billed
818

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine32$321,744
VraylarCariprazine Hcl33$48,895
SpravatoEsketamine Hcl38$47,257
AuvelityDextromethorphan Hbr/Bupropion21$26,994
BelsomraSuvorexant49$21,577
TrintellixVortioxetine Hydrobromide17$7,877
Vilazodone Hcl29$3,869
Eszopiclone53$1,616
Aripiprazole34$1,486
Duloxetine Hcl50$1,473
Bupropion XlBupropion Hcl56$1,370
Ziprasidone Hcl19$1,305
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine34$1,247
Lurasidone Hcl17$1,170
Clozapine13$1,019

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo$570$321,74432 claims
AbbVieVraylar$1,633$48,89533 claims
Johnson & JohnsonSpravato$999$47,25738 claims
Axsome Therapeutics, Inc.Auvelity$295$26,99421 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$737$7,87717 claims
Almatica Pharma LLCSertraline Hcl$279$21835 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,954 psychiatry providers in California.

Other psychiatry in Monterey

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →